CL
CND Life Sciences, Inc.
SEC filingBiotechnology · Scottsdale, AZ
Amount raised$6.3Msold at filing
Total offering$6.3M
Investors in the raise14count reported to the SEC
FiledAug 3, 2026first sale Jun 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Richard J. MorelloExecutive Officer, Director
Christopher J. GibbonsDirector
Peter J. HarrisExecutive Officer, Director
Enrique J. CarrazanaDirector
Jack J. SeaverDirector
Todd J. LevineExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.